Department of Cardiology, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, PR China; Center for Molecular and Translational Medicine, Georgia State University, 157 Decatur Street SE, Atlanta, GA 30303, USA.
Center for Molecular and Translational Medicine, Georgia State University, 157 Decatur Street SE, Atlanta, GA 30303, USA.
Biomed Pharmacother. 2022 Jun;150:113040. doi: 10.1016/j.biopha.2022.113040. Epub 2022 Apr 29.
Several metabolites from the kynurenine pathway of tryptophan metabolism play a critical role in vascular function and vascular wall remodeling. This study aimed to test whether metabolite kynurenic acid (KYNA) from the kynurenine pathway relaxes blood vessels.
We employed histological staining, in vitro cell culture, Western blotting, real-time PCR, and nitric oxide detection to validate kynurenine aminotransferase (KAT) localization in the vasculature as well as KYNA action on endothelial cells. We also detected vascular reactivity by organ chamber and monitored blood pressure by telemetry to investigate the regulation effect of KYNA on vascular tone. The results presented that perivascular adipose tissue (PVAT) from mice thoracic aorta had robust staining of anti-KAT1 and KYNA than PVAT from the abdominal aorta and mesenteric artery, which is consistent with the expression profile of brown adipocyte marker uncoupling protein 1. KYNA, metabolized from kynurenine by KAT, relaxed pre-contracted both aortic ring and mesenteric artery. In addition, KYNA derived from KAT in PVAT participates in the cross-talk between PVAT and vessel by mediating PVAT inhibition on agonist-induced thoracic aorta contraction. Furthermore, intraperitoneal injection of KYNA in mice reduced blood pressure. The vessel relaxation effect of KYNA was through the endothelium-dependent PI3K-Akt-eNOS pathway. Finally, the high-fat diet decreased KAT1 expression in perithoracic aortic fat and led to KYNA reduction in blood.
Our research identified KYNA generated by KAT as a novel perivascular brown adipocyte-derived vascular relaxation factor and suggests that KYNA reduction is a critical event in vascular dysfunction under obese condition.
色氨酸代谢中犬尿酸途径的几种代谢产物在血管功能和血管壁重塑中起着关键作用。本研究旨在测试犬尿酸途径中的代谢产物犬尿酸(KYNA)是否能使血管松弛。
我们采用组织学染色、体外细胞培养、Western blot、实时 PCR 和一氧化氮检测,验证了犬尿酸氨基转移酶(KAT)在血管中的定位以及 KYNA 对内皮细胞的作用。我们还通过器官室检测血管反应性,并通过遥测监测血压,以研究 KYNA 对血管张力的调节作用。结果表明,与来自腹主动脉和肠系膜动脉的 PVAT 相比,来自小鼠胸主动脉的 PVAT 具有更强的抗 KAT1 和 KYNA 染色,这与棕色脂肪细胞标志物解偶联蛋白 1 的表达谱一致。KYNA 由 KAT 从犬尿酸代谢而来,可松弛预收缩的主动脉环和肠系膜动脉。此外,PVAT 中的 KAT 产生的 KYNA 通过介导 PVAT 抑制激动剂诱导的胸主动脉收缩,参与了 PVAT 与血管之间的串扰。此外,KYNA 腹腔内注射可降低小鼠血压。KYNA 的血管舒张作用是通过内皮依赖性 PI3K-Akt-eNOS 通路。最后,高脂肪饮食降低了胸主动脉周围脂肪中的 KAT1 表达,并导致血液中 KYNA 减少。
我们的研究确定了 KAT 产生的 KYNA 是一种新型的血管周围棕色脂肪细胞衍生的血管舒张因子,并表明肥胖状态下血管功能障碍的关键事件是 KYNA 减少。